Most common complication of blood transfusion leading to death?
**Core Concept**
The most common complication of blood transfusion leading to death is a severe and potentially life-threatening condition that arises due to the introduction of foreign blood components into the recipient's circulation. This complication is a result of the interaction between the donor's blood and the recipient's immune system.
**Why the Correct Answer is Right**
The correct answer is Transfusion-Related Acute Lung Injury (TRALI). TRALI is a condition characterized by the sudden onset of non-cardiogenic pulmonary edema, leading to hypoxemia and potentially respiratory failure. This occurs when the transfused blood contains antibodies against the recipient's leukocytes, which bind to the endothelial cells lining the pulmonary capillaries, causing damage and increased vascular permeability. The resulting fluid shift and inflammation lead to the accumulation of fluid in the lungs, compromising gas exchange and ultimately threatening the patient's life.
**Why Each Wrong Option is Incorrect**
**Option A:** Hemolytic Transfusion Reaction is a severe complication of blood transfusion, but it is not the most common cause of death. It occurs when the recipient's immune system reacts to the transfused red blood cells, leading to their destruction.
**Option B:** Transfusion-Associated Circulatory Overload (TACO) is a condition that occurs when the transfused blood volume exceeds the recipient's circulatory capacity, leading to hypervolemia and potentially cardiac failure. While TACO can be life-threatening, it is less common than TRALI.
**Option C:** Febrile Non-Hemolytic Transfusion Reaction (FNHTR) is a mild to moderate reaction characterized by fever, chills, and sometimes hypertension. While uncomfortable for the recipient, FNHTR is rarely life-threatening and is not the most common cause of transfusion-related mortality.
**Clinical Pearl / High-Yield Fact**
To minimize the risk of TRALI, it is essential to carefully screen blood donors for the presence of antibodies against the recipient's leukocytes and to use leukoreduced blood products when possible.
**Correct Answer:** D. Transfusion-Related Acute Lung Injury (TRALI).